We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNBR
1301
DELISTED
Sleep Number
SNBR
| $4.61M | 0.01% |
93,688
+5,026
| +6% | +$239K |
|
1302
City Holding Co
CHCO
$2.06B
| $4.61M | 0.01% |
56,264
+2,939
| +6% | +$233K |
|
1303
Urban Outfitters
URBN
$6.65B
| $4.6M | 0.01% |
165,750
-10,839
| -6% | -$301K |
|
|
PE
1304
DELISTED
PARSLEY ENERGY INC
PE
| $4.58M | 0.01% |
242,143
+2,645
| +1% | +$43.7K |
|
1305
Dycom Industries
DY
$12.4B
| $4.57M | 0.01% |
96,826
+1,699
| +2% | +$82.7K |
|
1306
Independence Realty Trust
IRT
$4.01B
| $4.56M | 0.01% |
323,997
+22,769
| +8% | +$332K |
|
|
AVP
1307
DELISTED
Avon Products, Inc.
AVP
| $4.56M | 0.01% |
808,298
+58,091
| +8% | +$270K |
|
|
IRBT
1308
DELISTED
iRobot
IRBT
| $4.56M | 0.01% |
90,032
+6,255
| +7% | +$314K |
|
|
ECOL
1309
DELISTED
US Ecology, Inc.
ECOL
| $4.55M | 0.01% |
78,618
+10,767
| +16% | +$639K |
|
|
SWN
1310
DELISTED
Southwestern Energy Company
SWN
| $4.55M | 0.01% |
1,878,612
+61,300
| +3% | +$127K |
|
1311
Dine Brands
DIN
$452M
| $4.54M | 0.01% |
54,405
+2,393
| +5% | +$186K |
|
1312
Popular Inc
BPOP
$11.3B
| $4.54M | 0.01% |
77,289
+117
| +0.2% | +$6.53K |
|
1313
Armstrong World Industries
AWI
$7.8B
| $4.53M | 0.01% |
48,231
+817
| +2% | +$78K |
|
|
MYOK
1314
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $4.53M | 0.01% |
62,179
+2,852
| +5% | +$173K |
|
1315
Howard Hughes
HHH
$3.91B
| $4.53M | 0.01% |
37,437
+415
| +1% | +$46K |
|
|
FBC
1316
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $4.51M | 0.01% |
117,852
+23,759
| +25% | +$888K |
|
1317
Materion
MTRN
$6.12B
| $4.49M | 0.01% |
75,599
+3,813
| +5% | +$226K |
|
1318
Coca-Cola Consolidated
COKE
$12.3B
| $4.48M | 0.01% |
157,780
+6,260
| +4% | +$175K |
|
1319
Iovance Biotherapeutics
IOVA
$2B
| $4.46M | 0.01% |
161,301
+6,498
| +4% | +$148K |
|
|
LNW
1320
DELISTED
Light & Wonder
LNW
| $4.46M | 0.01% |
166,631
-921
| -0.5% | -$23.7K |
|
1321
MGIC Investment
MTG
$6.24B
| $4.46M | 0.01% |
314,657
+968
| +0.3% | +$13.4K |
|
1322
First Merchants
FRME
$2.73B
| $4.45M | 0.01% |
107,089
+2,444
| +2% | +$97.6K |
|
|
AYX
1323
DELISTED
Alteryx Inc
AYX
| $4.45M | 0.01% |
44,430
+1,067
| +2% | +$108K |
|
|
BRKL
1324
DELISTED
Brookline Bancorp
BRKL
| $4.45M | 0.01% |
270,036
+12,806
| +5% | +$202K |
|
|
ICPT
1325
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $4.44M | 0.01% |
35,848
+3,139
| +10% | +$281K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.